Randomised controlled trial of tetanus treatment with antitetanus immunoglobulin by the intrathecal or intramuscular route

British Medical Journal

Volumn 328, Issue 7440, 2004, Pages 615-617

  De Barros Miranda Filho, Demócrito ^a,d   De Alencar Ximenes, Ricardo Arraes ^a   Alci Barone, Antônio ^c   Luis Vaz, Vicente ^a   Gomes Vieira, Aderbal ^b   Gonçalves Albuquerque, Valéria Maria ^a  

^a UNIVERSIDADE DE PERNAMBUCO   (Brazil)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

TETANUS ANTIBODY;

ARTICLE; ARTIFICIAL VENTILATION; ASSISTED VENTILATION; BRAZIL; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFECT; HEADACHE; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MENINGITIS; MORTALITY; MUSCLE SPASM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY FAILURE; RESPIRATORY TRACT INFECTION; SIDE EFFECT; TETANUS; TREATMENT OUTCOME;

EID: 1542719520     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Sanders RKM, Martyn B, Joseph R, Peacock ML. Intrathecal antitetanus serum (horse) in the treatment of tetanus. Lancet 1977;i:974-7.
2. Vakil BJ, Armitage P, Clifford RE, Laurence DR. Therapeutic trial of intracisternal human tetanus immunoglobulin in clinical tetanus. Trans R Soc Trop Med Hyg 1979;73:579-83.
3. Gupta PS, Goyal S, Kapoor R, Batra VK, Jain BK. Intrathecal human tetanus immunoglobulin in early tetanus. Lancet 1980;ii:439-40.
4. Keswani NK, Singh AK, Upadhyana KD. Intrathecal tetanus anti-toxin in moderate and severe tetanus. J Indian Med Assoc 1980;75:67-9.
5. Rossano C, Giugliano F. Prime esperienze e risultati terapeutici con immunoglobuline umane andtetaniche per via subaracnoidea. Minerva Anestesiol 1970;36:725-7.
6. Ildirim I. Intrathecal treatment of tetanus with antitetanus serum and prednisolone mixture. In: International Conference on Tetanus, São Paulo. Pan American Health Organisation Scientific Publication 1972;253:119-26.
7. 2 - nolíqüor e no sangue. Revista brasileira Clinica e Terapêutica 1980;9:301-19.
8. Sun KO, Chan YW, Cheung RTF, So PC, Yu YL, Li PCK. Management of tetanus: a review of 18 cases. J R Soc Med 1994;87:135-7.
9. Gallais, H. Intérêt de l'administration intrathécale de sérum antitétanique et de corticoïdes pour le treatment du tétanos déclaré. La Nouvelle Presse médicale 1977;6:571.
10. List WF. The immediate treatment of tetanus with high doses of human tetanus antitoxin. Notfallmedizin 1981;7:731-3.
11. Thomas PP, Crowell EB, Mathew M. Intrathecal anti-tetanus serum (ATS) and parenteral betamethasone in treatment of tetanus. Trans R Soc Trop Med Hyg 1982;76:620-3.
12. Abrutyn E, Berlin JA. Intrathecal therapy in tetanus, a meta-analysis. JAMA 1991;266:2262-7.
13. Friedman LM, Furberg CD, Demets DL. Fundamentals of clinical trials. 3rd ed. St Louis, MI: Mosby, 1996.
14. Miranda Filho DB, Ximenes RAA, Bernardino SN, Escarião AG. Caracterização epidemiológica do tétano no estado de Pernambuco no período de 1981 a 1995. Resumos do IX Congresso Brasileiro de Infectologia; 1996; Aug 25-9; Recife. Sociedade Brasileira de Infectologia.
15. Miranda Filho D, Ximenes R, Barone A, Vaz V, Vieira Classificaç ão clínica de pacientes com tétano para monitoramento da resposta a medidas terapêuticas. Braz J Infect Dis 2003;7(suppl 1):S18.
16. Armitage P, Clifford R. Prognosis in tetanus: use of data from therapeutic trial. J Infect Dis 1978;138:1-8.
17. Miranda Filho DB, Ximenes RAA, Bernardino SN, Escarião AG. Identification of risk factors for death from tetanus in Pernambuco, Brazil. A case control study. Rev Inst Med Trop Sao Paulo 2000;42:333-9.
18. Barone AA, Raineri HC, Ferreira JM. Tétano: aspectos epidemiológicos, clínicos e terapêuticos. Análise de 461 casos. Rev Hosp Clin Fac Med Sao Paulo 1976;31:215-25.